Immutep
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap48.47M
Market cap48.47M
Price-Earnings ratio-0.90
Price-Earnings ratio-0.90
Dividend yield—
Dividend yield—
Average volume518.40K
Average volume518.40K
High today$0.3499
High today$0.3499
Low today$0.3141
Low today$0.3141
Open price$0.3378
Open price$0.3378
Volume256.47K
Volume256.47K
52 Week high$3.53
52 Week high$3.53
52 Week low$0.2928
52 Week low$0.2928
IMMP News
Simply Wall St 6d
Broker Revenue Forecasts For Immutep Limited Are Surging Higher - simplywall.st...
TipRanks 6d
Immutep provides update on development strategy for eftilagimod alfaImmutep (IMMP) provided an update on its development strategy for eftilagimod alfa. Following the early discontinuation of the TACTI-004 study, Immutep has been...
TipRanks 6d
Immutep Refocuses Efti Development After Manufacturing ProbeAn announcement from Immutep Ltd ( (AU:IMM) ) is now available. Immutep has outlined a focused development strategy for eftilagimod alfa that concentrates on h...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.